Tredje Ap Fonden Royalty Pharma PLC Transaction History
Tredje Ap Fonden
- $10.7 Billion
- Q4 2024
A detailed history of Tredje Ap Fonden transactions in Royalty Pharma PLC stock. As of the latest transaction made, Tredje Ap Fonden holds 51,175 shares of RPRX stock, worth $1.73 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
51,175
Previous 102,350
50.0%
Holding current value
$1.73 Million
Previous $2.9 Million
54.92%
% of portfolio
0.01%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding RPRX
# of Institutions
431Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.34 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$777 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$573 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$477 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...